Live Quote · NASDAQSTOKHealthcare· Biotechnology

Stoke Therapeutics, Inc.

$26.81▼ 0.45%($-0.12)
MKT CAP $1.75BNEXT EARNINGS Mar 15, 2027
50%
Bullish
TickerSpark Score
61/100
▌ Mixed
33
Valuation
40
Profitability
100
Growth
84
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a STOK research report →

Analyst Price Target
$50.50+88.4% vs. today

Range $43 – $58

Analyst RatingBuy
13 Buy3 Hold0 Sell

Price Chart

-2.86% · this period
$38.35$30.43$22.50Nov 20May 26Nov 20
52-Week Range26% of range
Low
$22.05
Current
$26.81
High
$40.22